Robert Boyce, ACA

Rob Boyce is the CEO of Plakous Therapeutics, a biotech start-up in Winston-Salem, NC that is developing a therapy to prevent a rare pediatric disease, Necrotizing Enterocolitis. Rob has been working in healthcare and life sciences throughout his career. He has been part of several start-up companies in diagnostics, pharmaceutical marketing, and biotech. He started his business career at Johnson & Johnson, marketing the Tylenol Brand. Rob launched his career as a naval aviator flying the Navy’s E-2C Hawkeye.